New national standard for intensive care pharmacists
05 May, 2021The standardised guidelines place pharmacists as key members of the multidisciplinary medical team caring for patients in the ICU.
Evidence urgently needed on how to safely withdraw patients from antidepressants
03 May, 2021 by Amy SarcevicResearchers at the Cochrane Collaboration reviewed 33 studies involving nearly 5000 participants, relating to antidepressant discontinuation.
The collaboration igniting malaria drug discovery
27 April, 2021Johnson & Johnson Innovation has facilitated a collaboration between WEHI and Janssen Pharmaceutica NV to ignite the development of antimalarial drug candidates.
Putting pharmacists where they're needed most
27 April, 2021 by Kristin Michaels, SHPA CEOSHPA will continue to advocate for investment in embedding geriatric medicine pharmacists as part of clinical pharmacy services for aged-care residents.
AstraZeneca vaccine myths debunked
14 April, 2021 by Amy SarcevicAustralians are being reminded that a causal relationship between blood clotting and adenovirus vector-based vaccines has still not been established, and that — should it be — the risk remains far lower than that of common medications.
New cell-based flu vaccine to be rolled out this month
07 April, 2021 by Amy SarcevicThis winter, for the first time, a new cell-based flu vaccine will be introduced in Australia, in a bid to boost the efficacy rates of national immunisation programs.
Pausing the vaccine rollout will claim, not protect, lives, says Professor
22 March, 2021 by Amy SarcevicCountries that have opted to pause the AstraZeneca vaccine amid unsubstantiated blood clotting fears are actively choosing to end lives, according to Professor Bruce Thompson.
Compulsory vaccines possible but unlikely, says law professor
08 March, 2021 by Amy SarcevicWhatever the government's intention, Prof Stewart believes a mandate should be the "final instrument" in its quest to roll out a vaccination program.
New MS treatment available on PBS
04 March, 2021Australians living with relapsing-remitting multiple sclerosis can now access a new treatment option with the listing of Zeposia (ozanimod) on the PBS.
Vaccine rollout may face delays
11 February, 2021 by Amy SarcevicInsufficient manufacturing infrastructure and incorrect handling after dispatch are creating supply shortfalls and wastage around the world.
Active ingredient prescribing comes into effect
04 February, 2021 by Matthew Grant, Monash UniversityDoctors must now prescribe drugs using their chemical name, not brand names. That's good news for patients.
Hospital pharmacists prepare for vaccine rollout
27 January, 2021With COVID-19 vaccinations set to roll out in less than one month, Australia's hospital pharmacists are preparing for their central role in the administration process.
How soon will we reach herd immunity for COVID-19?
25 January, 2021 by Amy SarcevicAchieving herd immunity for COVID-19 may be a challenge through current vaccination programs, research from the Imperial College London has found.
Delaying the second dose of Pfizer’s vaccine could be dangerous, immunologist warns
12 January, 2021 by Amy SarcevicAn immunologist at the University of Queensland has cautioned over the UK's decision to delay second doses of the Pfizer vaccine.
The psychology of anti-vaxxers
14 December, 2020 by Amy SarcevicPsychologists have shed light on why seemingly intelligent people ignore the evidence base supporting vaccines and label them unsafe, despite having little to no expertise on scientific methodology.
